Bakhtiari, Mohammad
Bonn, Stefan
Theis, Fabian
Zolotareva, Olga
Baumbach, Jan
Funding for this research was provided by:
European Union’s Horizon Europe research and innovation programme (101137278, 101137278)
European Union's Horizon2020 research and innovation programme (826078)
German Federal Ministry of Education and Research (01IS21079)
Universität Hamburg
Article History
Received: 26 July 2024
Accepted: 3 July 2025
First Online: 22 July 2025
Declarations
:
: Not applicable.
: Not applicable.
: F.J.T. consults for Immunai Inc., CytoReason Ltd, Cellarity, BioTuring Inc., and Genbio.AI Inc., and has an ownership interest in Dermagnostix GmbH and Cellarity. No other author declares competing interests.